Latest filing: trade of 20 Apr 2022 for TCM Global Frontier High Dividend Equity, €34k. The register gives no publication date.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Riemersma W.Y.: trading record in brief
Riemersma W.Y. is a declared insider of TCM Global Frontier High Dividend Equity, with filings sourced from AFM. We count 2 filings; the first trade dates from 4 October 2019 and the latest from 20 April 2022.
In open-market terms, that means 1 purchase worth €30k on one side and 1 sale worth €34k on the other. Netting one side against the other leaves €4,287 of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2022 alone, the filings show no purchases and 1 sale.
The latest filing, published on 25 April 2022, reports an open-market sale of €34k in TCM Global Frontier High Dividend Equity. The last insider purchase was made public on 9 October 2019, 2,587 days ago. This summary is built from AFM disclosures alone and does not predict where the share price will go.
Companies and markets linked to Riemersma W.Y.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 300 shares@ €114.29Gewoon aandeelOTCISIN LU1730853543AFM:MAR19:2022042013BEFB91-1EC2-EC11-A2EE-005056BB4E9F
- 300 shares@ €100.00TCM Global Frontier High Dividend Equity - AandeelOTCISIN LU1730853386AFM:MAR19:2019100465FE74F4-E44C-EA11-80F9-005056BB7B10Canonical exit: 2 Jan 2020 (T+90)
2 of 2 declarations